cik stringclasses 1
value | date stringlengths 8 8 | form stringclasses 4
values | sentenceCount int64 0 2.33k | sentence stringlengths 2 5.25k | filename stringlengths 40 40 |
|---|---|---|---|---|---|
0000320193 | 20100125 | 10-K/A | 609 | During the years ended September 26, 2009 and September 27, 2008, the Company did not recognize any material impairment charges. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 610 | As of September 26, 2009, the Company does not consider any of its investments to be other-than-temporarily impaired. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 611 | Derivative Financial Instruments
The Company uses derivatives to partially offset its business exposure to foreign currency exchange risk. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 612 | The Company may enter into foreign currency forward and option contracts to offset some of the foreign exchange risk of expected future cash flows on certain forecasted revenue and cost of sales, of net investments in certain foreign subsidiaries, and on certain existing assets and liabilities. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 613 | To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s subsidiaries whose functional currency is the U.S. dollar, hedge a portion of forecasted foreign currency revenue. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 614 | The Company’s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies, may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries’ functional currencies. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 615 | The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases for three to six months. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 616 | To help protect the net investment in a foreign operation from adverse changes in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 617 | The Company may also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 618 | However, the Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons, including but not limited to immateriality, accounting considerations and the prohibitive economic cost of hedging particular exposures. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 619 | There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange rates. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 620 | The Company’s accounting policies for these instruments are based on whether the instruments are designated as hedge or non-hedge instruments. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 621 | The Company records all derivatives on the Consolidated Balance Sheets at fair value. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 622 | The effective portions of cash flow hedges are recorded in other comprehensive income until the hedged item is recognized in earnings. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 623 | The effective portions of net investment hedges are recorded in other comprehensive income as a part of the cumulative translation adjustment. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 624 | Derivatives that are not designated as hedging instruments and the ineffective portions of cash flow hedges and net investment hedges are adjusted to fair value through earnings in other income and expense. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 625 | The Company had a net deferred gain associated with cash flow hedges of approximately $1 million and $19 million, net of taxes, recorded in other comprehensive income as of September 26, 2009 and September 27, 2008, respectively. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 626 | Other comprehensive income associated with cash flow hedges of foreign currency revenue is recognized as a component of net sales in the same period as the related revenue is recognized, and other comprehensive income related to cash flow hedges of inventory purchases is recognized as a component of cost of sales in th... | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 627 | As of September 26, 2009, the hedged transactions are expected to occur within six months. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 628 | Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two month time period. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 629 | Deferred gains and losses in other comprehensive income associated with such derivative instruments are reclassified immediately into earnings through other income and expense. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 630 | Any subsequent changes in fair value of such derivative instruments also are reflected in current earnings unless they are re-designated as hedges of other transactions. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 631 | The Company did not recognize any material net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during 2009, 2008 and 2007. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 632 | The Company had an unrealized net loss on net investment hedges of $2 million and $1 million, net of taxes, included in the cumulative translation adjustment account of accumulated other comprehensive income (“AOCI”) as of September 26, 2009 and September 27, 2008, respectively. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 633 | The ineffective portions and amounts excluded from the effectiveness test of net investment hedges are recorded in current earnings in other income and expense. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 634 | The Company recognized in earnings a net gain of $133 million on foreign currency forward and option contracts not designated as hedging instruments during the year ended September 26, 2009. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 635 | The following table shows the notional principal and credit risk amounts of the Company’s derivative instruments outstanding as of September 26, 2009 and September 27, 2008 (in millions):
The notional principal amounts for derivative instruments provide one measure of the transaction volume outstanding as of September ... | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 636 | The credit risk amounts represent the Company’s gross exposure to potential accounting loss on these transactions if all counterparties failed to perform according to the terms of the contract, based on then-current currency exchange rates at each respective date. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 637 | The Company’s gross exposure on these transactions may be further mitigated by collateral received from certain counterparties. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 638 | The Company’s exposure to credit loss and market risk will vary over time as a function of currency exchange rates. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 639 | Although the table above reflects the notional principal and credit risk amounts of the Company’s foreign exchange instruments, it does not reflect the gains or losses associated with the exposures and transactions that the foreign exchange instruments are intended to hedge. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 640 | The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 641 | The Company generally enters into master netting arrangements, which reduce credit risk by permitting net settlement of transactions with the same counterparty. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 642 | To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received when the net fair value of certain financial instruments exceeds contractually established thresholds. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 643 | The Company presents its derivative assets
and derivative liabilities at their gross fair values. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 644 | The Company did not record a material amount of cash collateral related to the derivative instruments under its master netting arrangements as of September 26, 2009. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 645 | The Company did not have any derivative instruments with credit risk-related contingent features that would require it to post additional collateral as of September 26, 2009. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 646 | The estimates of fair value are based on applicable and commonly used pricing models and prevailing financial market information as of September 26, 2009. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 647 | Refer to Note 4, “Fair Value Measurements” of this Form 10-K, for additional information on the fair value measurements for all financial assets and liabilities, including derivative assets and derivative liabilities, that are measured at fair value in the consolidated financial statements on a recurring basis. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 648 | The following tables shows the Company’s derivative instruments measured at gross fair value as reflected in the Consolidated Balance Sheets as of September 26, 2009 and September 27, 2008 (in millions):
(a) All derivative assets are recorded as other current assets in the Consolidated Balance Sheets. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 649 | (b) All derivative liabilities are recorded as accrued expenses in the Consolidated Balance Sheets. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 650 | The following table shows the effect of the Company’s derivative instruments designated as cash flow and net investment hedges in the Consolidated Statements of Operations for the year ended September 26, 2009 (in millions):
(a) Refer to Note 8, “Shareholders’ Equity and Stock-Based Compensation” of this Form 10-K, whi... | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 651 | Accounts Receivable
Trade Receivables
The Company distributes its products through third-party distributors, cellular network carriers, and resellers and directly to certain education, consumer and enterprise customers. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 652 | The Company generally does not require collateral from its customers; however, the Company will require collateral in certain instances to limit credit risk. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 653 | In addition, when possible, the Company attempts to limit credit risk on trade receivables with credit insurance for certain customers in Latin America, Europe, Asia, and Australia, or by requiring third-party financing, loans or leases to support credit exposure. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 654 | These credit-financing arrangements are directly between the third-party financing company and the end customer. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 655 | As such, the Company generally does not assume any recourse or credit risk sharing related to any of these arrangements. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 656 | However, considerable trade receivables not covered by collateral, third-party financing arrangements, or credit insurance are outstanding with the Company’s distribution and retail channel partners. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 657 | Trade receivables from one of the Company’s customers accounted for 16% of trade receivables as of September 26, 2009 and two of the Company’s customers accounted for 15% and 10%, respectively, of trade receivables as of September 27, 2008. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 658 | The following table summarizes the activity in the allowance for doubtful accounts for the three years ended September 26, 2009 (in millions):
Vendor Non-Trade Receivables
The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of raw material components to these manufact... | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 659 | The Company purchases these raw material components directly from suppliers. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 660 | These non-trade receivables, which are included in the Consolidated Balance Sheets in other current assets, totaled $1.7 billion and $2.3 billion as of September 26, 2009 and September 27, 2008, respectively. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 661 | Vendor non-trade receivables from two of the Company’s vendors accounted for 40% and 36%, respectively, of non-trade receivables as of September 26, 2009 and two of the Company’s vendors accounted for 47% and 38%, respectively, of non-trade receivables as of September 27, 2008. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 662 | The Company does not reflect the sale of these components in net sales and does not recognize any profits on these sales until the related products are sold by the Company, at which time any profit is recognized as a reduction of cost of sales. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 663 | Note 4 - Fair Value Measurements
The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 664 | When determining the fair value measurements for assets and liabilities, which are required to be recorded at fair value, the Company considers the principal or most advantageous market in which the Company would transact and the market-based risk measurements or assumptions that market participants would use in pricin... | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 665 | The Company applies the following fair value hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:
Level 1 - Quoted prices in active markets fo... | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 666 | Level 2 - Observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the asset... | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 667 | Level 3 - Inputs that are generally unobservable and typically reflect management’s estimates of assumptions that market participants would use in pricing the asset or liability. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 668 | The Company’s valuation techniques used to measure the fair value of money market funds and certain marketable equity securities were derived from quoted prices in active markets for identical assets or liabilities. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 669 | The valuation techniques used to measure the fair value of all other financial instruments, all of which have counterparties with high credit ratings, were valued based on quoted market prices or model driven valuations using significant inputs derived from or corroborated by observable market data. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 670 | Assets/Liabilities Measured at Fair Value on a Recurring Basis
The following table presents the Company’s assets and liabilities measured at fair value on a recurring basis as of September 26, 2009 (in millions):
(a) The total fair value amounts for assets and liabilities also represent the related carrying amounts. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 671 | The following table summarizes the Company’s assets and liabilities measured at fair value on a recurring basis as presented in the Company’s Consolidated Balance Sheet as of September 26, 2009 (in millions):
(a) The total fair value amounts for assets and liabilities also represent the related carrying amounts. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 672 | Note 5 - Consolidated Financial Statement Details
The following tables show the Company’s consolidated financial statement details as of September 26, 2009 and September 27, 2008 (in millions):
Other Current Assets
Property, Plant and Equipment
Other Assets
Accrued Expenses
Non-Current Liabilities
Note 6 - Goodwill and... | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 673 | The following table summarizes the components of gross and net intangible asset balances as of September 26, 2009 and September 27, 2008 (in millions):
In 2008, the Company completed an acquisition of a business for total cash consideration, net of cash acquired, of $220 million, of which $169 million has been allocate... | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 674 | The Company’s goodwill is allocated primarily to the America’s reportable operating segment. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 675 | Amortization expense related to acquired intangible assets was $53 million, $46 million and $35 million in 2009, 2008 and 2007, respectively. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 676 | As of September 26, 2009 and September 27, 2008, the remaining weighted-average amortization period for acquired technology was 7.2 years and 7.0 years, respectively. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 677 | Expected annual amortization expense related to acquired technology as of September 26, 2009, is as follows (in millions):
Note 7 - Income Taxes
The provision for income taxes for the three years ended September 26, 2009, consisted of the following (in millions):
The foreign provision for income taxes is based on forei... | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 678 | As of September 26, 2009 and September 27, 2008, $17.4 billion and $11.3 billion, respectively, of the Company’s cash, cash equivalents and marketable securities were held by foreign subsidiaries and are generally based in U.S. dollar-denominated holdings. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 679 | Amounts held by foreign subsidiaries are generally subject to U.S. income taxation on repatriation to the U.S. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 680 | The Company’s consolidated financial statements provide for any related tax liability on amounts that may be repatriated, aside from undistributed earnings of certain of the Company’s foreign subsidiaries that are intended to be indefinitely reinvested in operations outside the U.S. U.S. income taxes have not been prov... | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 681 | It is not practicable to determine the income tax liability that might be incurred if these earnings were to be distributed. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 682 | Deferred tax assets and liabilities reflect the effects of tax losses, credits, and the future income tax effects of temporary differences between the consolidated financial statement carrying amounts of existing assets and liabilities and their respective tax bases and are measured using enacted tax rates that apply t... | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 683 | As of September 26, 2009 and September 27, 2008, the significant components of the Company’s deferred tax assets and liabilities were (in millions):
A reconciliation of the provision for income taxes, with the amount computed by applying the statutory federal income tax rate (35% in 2009, 2008 and 2007) to income befor... | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 684 | For stock options, the Company receives an income tax benefit calculated as the difference between the fair market value of the stock issued at the time of the exercise and the option price, tax effected. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 685 | The Company had net tax benefits from employee stock plan awards of $246 million, $770 million and $398 million in 2009, 2008 and 2007, respectively, which were reflected as increases to common stock. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 686 | On October 3, 2008, the Tax Extenders and Alternative Minimum Tax Relief Act of 2008 was signed into law. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 687 | This bill, among other things, retroactively extended the expired research and development tax credit. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 688 | As a result, the Company recorded a tax benefit of $42 million in the first quarter of 2009 to account for the retroactive effects of the research credit extension. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 689 | Uncertain Tax Positions
As discussed in Note 1, “Summary of Significant Accounting Policies” the Company adopted new accounting principles on accounting for uncertain tax positions in 2008. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 690 | Under these new principles, tax positions are evaluated in a two-step process. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 691 | The Company first determines whether it is more likely than not that a tax position will be sustained upon examination. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 692 | If a tax position meets the more-likely-than-not recognition threshold it is then measured to determine the amount of benefit to recognize in the financial statements. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 693 | The tax position is measured as the largest amount of benefit that is greater than 50 percent likely of being realized upon ultimate settlement. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 694 | Upon adoption of these new principles, the Company’s cumulative effect of a change in accounting principle resulted in an increase to retained earnings of $11 million. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 695 | The Company had historically classified interest and penalties and unrecognized tax benefits as current liabilities. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 696 | Beginning with the adoption of these new principles, the Company classifies gross interest and penalties and unrecognized tax benefits that are not expected to result in payment or receipt of cash within one year as non-current liabilities in the Consolidated Balance Sheets. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 697 | The total amount of gross unrecognized tax benefits as of the date of adoption was $475 million, of which $209 million, if recognized, would affect the Company’s effective tax rate. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 698 | The Company’s total gross unrecognized tax benefits are classified as non-current liabilities in the Consolidated Balance Sheets. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 699 | As of September 26, 2009, the total amount of gross unrecognized tax benefits was $971 million, of which $307 million, if recognized, would affect the Company’s effective tax rate. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 700 | As of September 27, 2008, the total amount of gross unrecognized tax benefits was $506 million, of which $253 million, if recognized, would affect the Company’s effective tax rate. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 701 | On May 27, 2009, the United States Court of Appeals for the Ninth Circuit issued its ruling in the case of Xilinx, Inc. v. Commissioner, holding that stock-based compensation is required to be included in certain transfer pricing arrangements between a U.S. company and its offshore subsidiary. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 702 | As a result of the ruling in this case, the Company increased its liability for unrecognized tax benefits by approximately $86 million and decreased shareholders’ equity by approximately $78 million in the year ended September 26, 2009. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 703 | The aggregate changes in the balance of gross unrecognized tax benefits, which excludes interest and penalties, for the two years ended September 26, 2009, is as follows (in millions):
The Company’s policy to include interest and penalties related to unrecognized tax benefits within the provision for income taxes did n... | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 704 | As of the date of adoption, the Company had accrued $203 million for the gross interest and penalties relating to unrecognized tax benefits. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 705 | As of September 26, 2009 and September 27, 2008, the total amount of gross interest and penalties accrued was $291 million and $219 million, respectively, which is classified as non-current liabilities in the Consolidated Balance Sheets. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 706 | In 2009 and 2008, the Company recognized interest expense in connection with tax matters of $64 million and $16 million, respectively. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 707 | The Company is subject to taxation and files income tax returns in the U.S. federal jurisdiction and in many state and foreign jurisdictions. | 0001193125-10-012091/full-submission.txt |
0000320193 | 20100125 | 10-K/A | 708 | For U.S. federal income tax purposes, all years prior to 2002 are closed. | 0001193125-10-012091/full-submission.txt |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.